CVE-2020-27269

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.

Category

5.7
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.09%
Third-Party Advisory cisa.gov
Affected: n/a SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A
Published at:
Updated at:

References

Link Tags
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2020-27269?
CVE-2020-27269 has been scored as a medium severity vulnerability.
How to fix CVE-2020-27269?
To fix CVE-2020-27269, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-27269 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-27269 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-27269?
CVE-2020-27269 affects n/a SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.